| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Metabolic engineering of Escherichia coli for the production of L-valine based on transcriptome analysis and in silico gene knockout simulation.
|
Proc Natl Acad Sci U S A
|
2007
|
2.43
|
|
2
|
Thyroid nodules with initially nondiagnostic cytologic results: the role of core-needle biopsy.
|
Radiology
|
2013
|
2.34
|
|
3
|
Systems metabolic engineering of Escherichia coli for L-threonine production.
|
Mol Syst Biol
|
2007
|
2.18
|
|
4
|
Metabolic engineering of Escherichia coli for enhanced production of succinic acid, based on genome comparison and in silico gene knockout simulation.
|
Appl Environ Microbiol
|
2005
|
2.13
|
|
5
|
Diagnostic accuracy of ultrasound and 18-F-FDG PET or PET/CT for patients with suspected recurrent papillary thyroid carcinoma.
|
Ultrasound Med Biol
|
2010
|
2.04
|
|
6
|
Systems biotechnology for strain improvement.
|
Trends Biotechnol
|
2005
|
1.98
|
|
7
|
Ultrasonographic screening for detection of thyroid cancer in patients with Graves' disease.
|
Clin Endocrinol (Oxf)
|
2004
|
1.96
|
|
8
|
The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation.
|
J Clin Endocrinol Metab
|
2011
|
1.74
|
|
9
|
Constraints-based genome-scale metabolic simulation for systems metabolic engineering.
|
Biotechnol Adv
|
2009
|
1.60
|
|
10
|
Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery.
|
Mol Syst Biol
|
2011
|
1.50
|
|
11
|
Metabolic engineering of Escherichia coli for the production of polylactic acid and its copolymers.
|
Biotechnol Bioeng
|
2010
|
1.36
|
|
12
|
Systems biology as a foundation for genome-scale synthetic biology.
|
Curr Opin Biotechnol
|
2006
|
1.31
|
|
13
|
Application of systems biology for bioprocess development.
|
Trends Biotechnol
|
2008
|
1.30
|
|
14
|
Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma.
|
Clin Endocrinol (Oxf)
|
2009
|
1.27
|
|
15
|
Metabolite essentiality elucidates robustness of Escherichia coli metabolism.
|
Proc Natl Acad Sci U S A
|
2007
|
1.26
|
|
16
|
Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation.
|
Clin Endocrinol (Oxf)
|
2004
|
1.24
|
|
17
|
Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma.
|
J Clin Endocrinol Metab
|
2008
|
1.23
|
|
18
|
In silico identification of gene amplification targets for improvement of lycopene production.
|
Appl Environ Microbiol
|
2010
|
1.18
|
|
19
|
Systems metabolic engineering for chemicals and materials.
|
Trends Biotechnol
|
2011
|
1.17
|
|
20
|
Papillary thyroid carcinoma arising from a thyroglossal duct cyst: a single institution experience.
|
Endocr J
|
2013
|
1.16
|
|
21
|
Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population.
|
Eur J Endocrinol
|
2013
|
1.16
|
|
22
|
18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm.
|
J Clin Endocrinol Metab
|
2007
|
1.11
|
|
23
|
Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma.
|
Endocr J
|
2007
|
1.10
|
|
24
|
Genome-scale metabolic model of methylotrophic yeast Pichia pastoris and its use for in silico analysis of heterologous protein production.
|
Biotechnol J
|
2010
|
1.07
|
|
25
|
Relationship between serum free T4 (FT4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects.
|
Clin Endocrinol (Oxf)
|
2008
|
1.05
|
|
26
|
Metabolic engineering of microorganisms: general strategies and drug production.
|
Drug Discov Today
|
2008
|
1.04
|
|
27
|
Genome-scale metabolic network analysis and drug targeting of multi-drug resistant pathogen Acinetobacter baumannii AYE.
|
Mol Biosyst
|
2009
|
1.02
|
|
28
|
Low levels of serum vitamin D3 are associated with autoimmune thyroid disease in pre-menopausal women.
|
Thyroid
|
2014
|
1.01
|
|
29
|
Technical and oncologic safety of robotic thyroid surgery.
|
Ann Surg Oncol
|
2013
|
1.01
|
|
30
|
Metabolic engineering of Escherichia coli for the production of 1-propanol.
|
Metab Eng
|
2012
|
1.00
|
|
31
|
Long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level one year after initial treatment.
|
Thyroid
|
2012
|
1.00
|
|
32
|
Construction and optimization of synthetic pathways in metabolic engineering.
|
Curr Opin Microbiol
|
2010
|
0.99
|
|
33
|
The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma.
|
Eur J Endocrinol
|
2013
|
0.99
|
|
34
|
Clinical characteristics of primary thyroid lymphoma in Koreans.
|
Endocr J
|
2009
|
0.98
|
|
35
|
NRAS codon 61 mutation is associated with distant metastasis in patients with follicular thyroid carcinoma.
|
Thyroid
|
2014
|
0.98
|
|
36
|
Empiric high-dose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scan.
|
J Clin Endocrinol Metab
|
2010
|
0.95
|
|
37
|
Systemic inflammatory syndrome and hepatic inflammatory cell infiltration caused by an interleukin-6 producing pheochromocytoma.
|
Endocr J
|
2005
|
0.95
|
|
38
|
The genome-scale metabolic network analysis of Zymomonas mobilis ZM4 explains physiological features and suggests ethanol and succinic acid production strategies.
|
Microb Cell Fact
|
2010
|
0.95
|
|
39
|
Modified dynamic risk stratification for predicting recurrence using the response to initial therapy in patients with differentiated thyroid carcinoma.
|
Eur J Endocrinol
|
2013
|
0.95
|
|
40
|
Cystic versus predominantly cystic thyroid nodules: efficacy of ethanol ablation and analysis of related factors.
|
Eur Radiol
|
2012
|
0.94
|
|
41
|
Concurrent occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma in the same thyroid should be considered as coincidental.
|
Clin Endocrinol (Oxf)
|
2010
|
0.94
|
|
42
|
Prediction of metabolic fluxes by incorporating genomic context and flux-converging pattern analyses.
|
Proc Natl Acad Sci U S A
|
2010
|
0.94
|
|
43
|
Is routine central neck dissection necessary for the treatment of papillary thyroid microcarcinoma?
|
Clin Exp Otorhinolaryngol
|
2008
|
0.93
|
|
44
|
Serum antithyroglobulin antibodies interfere with thyroglobulin detection in fine-needle aspirates of metastatic neck nodes in papillary thyroid carcinoma.
|
J Clin Endocrinol Metab
|
2012
|
0.93
|
|
45
|
Metabolic flux analysis and metabolic engineering of microorganisms.
|
Mol Biosyst
|
2007
|
0.93
|
|
46
|
Development of chemically defined medium for Mannheimia succiniciproducens based on its genome sequence.
|
Appl Microbiol Biotechnol
|
2008
|
0.91
|
|
47
|
Intramedullary spinal cord metastasis from papillary thyroid carcinoma.
|
Thyroid
|
2011
|
0.91
|
|
48
|
In silico genome-scale metabolic analysis of Pseudomonas putida KT2440 for polyhydroxyalkanoate synthesis, degradation of aromatics and anaerobic survival.
|
Biotechnol J
|
2010
|
0.91
|
|
49
|
Core needle biopsy can minimise the non-diagnostic results and need for diagnostic surgery in patients with calcified thyroid nodules.
|
Eur Radiol
|
2014
|
0.90
|
|
50
|
Long-term consequence of elevated thyroglobulin in differentiated thyroid cancer.
|
Thyroid
|
2013
|
0.88
|
|
51
|
Genome-scale reconstruction and in silico analysis of the Ralstonia eutropha H16 for polyhydroxyalkanoate synthesis, lithoautotrophic growth, and 2-methyl citric acid production.
|
BMC Syst Biol
|
2011
|
0.87
|
|
52
|
Association between expression of X-linked inhibitor of apoptosis protein and the clinical outcome in a BRAF V600E-prevalent papillary thyroid cancer population.
|
Thyroid
|
2013
|
0.87
|
|
53
|
Lymphovascular invasion is associated with lateral cervical lymph node metastasis in papillary thyroid carcinoma.
|
Laryngoscope
|
2006
|
0.87
|
|
54
|
MetaFluxNet, a program package for metabolic pathway construction and analysis, and its use in large-scale metabolic flux analysis of Escherichia coli.
|
Genome Inform
|
2003
|
0.86
|
|
55
|
From genome sequence to integrated bioprocess for succinic acid production by Mannheimia succiniciproducens.
|
Appl Microbiol Biotechnol
|
2008
|
0.86
|
|
56
|
Effects of different doses of radioactive iodine for remnant ablation on successful ablation and on long-term recurrences in patients with differentiated thyroid carcinoma.
|
Nucl Med Commun
|
2011
|
0.86
|
|
57
|
Incorporating metabolic flux ratios into constraint-based flux analysis by using artificial metabolites and converging ratio determinants.
|
J Biotechnol
|
2007
|
0.85
|
|
58
|
Time trend in tumour size and characteristics of anaplastic thyroid carcinoma.
|
Clin Endocrinol (Oxf)
|
2012
|
0.84
|
|
59
|
ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy.
|
Cancer Sci
|
2014
|
0.84
|
|
60
|
Fed-batch culture of Escherichia coli for L-valine production based on in silico flux response analysis.
|
Biotechnol Bioeng
|
2010
|
0.84
|
|
61
|
Flux variability scanning based on enforced objective flux for identifying gene amplification targets.
|
BMC Syst Biol
|
2012
|
0.84
|
|
62
|
Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer.
|
Eur Radiol
|
2014
|
0.83
|
|
63
|
The influence of the BRAF V600E mutation in thyroid cancer cell lines on the anticancer effects of 5-aminoimidazole-4-carboxamide-ribonucleoside.
|
J Endocrinol
|
2011
|
0.82
|
|
64
|
Association of HLA-DR and -DQ genes with Graves disease in Koreans.
|
Hum Immunol
|
2005
|
0.82
|
|
65
|
Effects of low-dose and high-dose postoperative radioiodine therapy on the clinical outcome in patients with small differentiated thyroid cancer having microscopic extrathyroidal extension.
|
Thyroid
|
2014
|
0.81
|
|
66
|
Adjuvant radioactive therapy after reoperation for locoregionally recurrent papillary thyroid cancer in patients who initially underwent total thyroidectomy and high-dose remnant ablation.
|
J Clin Endocrinol Metab
|
2011
|
0.81
|
|
67
|
Ultrasound elastography for thyroid nodules: a reliable study?
|
Ultrasound Med Biol
|
2012
|
0.81
|
|
68
|
A cut-off value of basal serum calcitonin for detecting macroscopic medullary thyroid carcinoma.
|
Clin Endocrinol (Oxf)
|
2014
|
0.81
|
|
69
|
Differentiating the location of cervical lymph node metastasis is very useful for estimating the risk of distant metastases in papillary thyroid carcinoma.
|
Clin Endocrinol (Oxf)
|
2014
|
0.81
|
|
70
|
Recent advances in production of recombinant spider silk proteins.
|
Curr Opin Biotechnol
|
2012
|
0.81
|
|
71
|
Expression of chitinases in hypertrophied adenoids of children.
|
Otolaryngol Head Neck Surg
|
2011
|
0.80
|
|
72
|
Application of metabolic flux analysis in metabolic engineering.
|
Methods Enzymol
|
2011
|
0.79
|
|
73
|
Redifferentiation therapy with 13-cis retinoic acids in radioiodine-resistant thyroid cancer.
|
Endocr J
|
2008
|
0.79
|
|
74
|
Clinical outcomes of persistent radioiodine uptake in the neck shown by diagnostic whole body scan in patients with differentiated thyroid carcinoma after initial surgery and remnant ablation.
|
Clin Endocrinol (Oxf)
|
2010
|
0.79
|
|
75
|
Characteristic ultrasound feature of traumatic neuromas after neck dissection: direct continuity with the cervical plexus.
|
Thyroid
|
2012
|
0.79
|
|
76
|
Development of a gene knockout system for Ralstonia eutropha H16 based on the broad-host-range vector expressing a mobile group II intron.
|
FEMS Microbiol Lett
|
2010
|
0.78
|
|
77
|
Lipoic acid rescues DBA mice from early-onset age-related hearing impairment.
|
Neuroreport
|
2008
|
0.78
|
|
78
|
Susceptible alleles of the CD40 and CTLA-4 genes are not associated with the relapse after antithyroid withdrawal in Graves' disease.
|
Thyroid
|
2007
|
0.78
|
|
79
|
Genome-scale metabolic model of the fission yeast Schizosaccharomyces pombe and the reconciliation of in silico/in vivo mutant growth.
|
BMC Syst Biol
|
2012
|
0.78
|
|
80
|
Clinicopathological Features Associated With the Prognosis of Patients With Adrenal Cortical Carcinoma: Usefulness of the Ki-67 Index.
|
Medicine (Baltimore)
|
2016
|
0.77
|
|
81
|
Prediction of treatment response to ¹³¹I therapy by diffuse hepatic uptake intensity on post-therapy whole-body scan in patients with distant metastases of differentiated thyroid cancer.
|
Ann Nucl Med
|
2015
|
0.77
|
|
82
|
Expression of X-linked inhibitor of apoptosis protein in neoplastic thyroid disorder.
|
J Korean Med Sci
|
2011
|
0.77
|
|
83
|
Thyroglobulin level in fine-needle aspirates for preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: two different cutoff values according to serum thyroglobulin level.
|
Thyroid
|
2015
|
0.77
|
|
84
|
Periprosthetic supracondylar femoral fractures above total knee arthroplasty: comparison of the locking and non-locking plating methods.
|
Knee Surg Sports Traumatol Arthrosc
|
2013
|
0.76
|
|
85
|
Framework for network modularization and Bayesian network analysis to investigate the perturbed metabolic network.
|
BMC Syst Biol
|
2011
|
0.75
|
|
86
|
Re: Antiproliferation and redifferentiation in thyroid cancer cell line by polyphenol phytochemicals.
|
J Korean Med Sci
|
2011
|
0.75
|
|
87
|
THE ROLE OF CORE-NEEDLE BIOPSY FOR THYROID NODULES WITH INITIALLY NONDIAGNOSTIC FINE-NEEDLE ASPIRATION RESULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS.
|
Endocr Pract
|
2016
|
0.75
|
|
88
|
Selective Activation of Methane on Single-Atom Catalyst of Rhodium Dispersed on Zirconia for Direct Conversion.
|
J Am Chem Soc
|
2017
|
0.75
|
|
89
|
A mesoporous carbon-supported Pt nanocatalyst for the conversion of lignocellulose to sugar alcohols.
|
ChemSusChem
|
2013
|
0.75
|
|
90
|
HPLC analysis and pharmacokinetic characteristics of 11-hydroxyaclacinomycin X (ID-6105), a novel anthracycline, in rats and beagle dogs.
|
Biol Pharm Bull
|
2005
|
0.75
|
|
91
|
In vivo antitumor efficacy and cardiotoxicity of novel anthracycline ID6105 (11-hydroxy-aclacinomycin X, Hyrubicin).
|
Cancer Chemother Pharmacol
|
2005
|
0.75
|
|
92
|
Radial alignment of c-channel nanorods in 3D porous TiO2 for eliciting enhanced Li storage performance.
|
Chem Commun (Camb)
|
2015
|
0.75
|
|
93
|
Production of 4-hydroxybutyric acid by metabolically engineered Mannheimia succiniciproducens and its conversion to γ-butyrolactone by acid treatment.
|
Metab Eng
|
2013
|
0.75
|
|
94
|
Pharmacokinetics of 11-hydroxyaclacinomycin X (ID-6105), a novel anthracycline, after i.v. bolus multiple administration in rats.
|
Arch Pharm Res
|
2005
|
0.75
|
|
95
|
Contribution of the delayed-rectifier potassium channel Kv2.1 to acute spinal cord injury in rats.
|
BMB Rep
|
2010
|
0.75
|
|
96
|
Nasal polyp chitinolytic activity associated with smoking or allergy.
|
Int Forum Allergy Rhinol
|
2014
|
0.75
|
|
97
|
Comparing the Effectiveness and Safety of the Addition of and Switching to Aripiprazole for Resolving Antipsychotic-Induced Hyperprolactinemia: A Multicenter, Open-Label, Prospective Study.
|
Clin Neuropharmacol
|
2016
|
0.75
|
|
98
|
Association between STAT1 activity and BRAF mutations in papillary thyroid carcinomas.
|
J Surg Oncol
|
2012
|
0.75
|
|
99
|
A tailored catalyst for the sustainable conversion of glycerol to acrolein: mechanistic aspect of sequential dehydration.
|
ChemSusChem
|
2014
|
0.75
|
|
100
|
Alpha-lipoic acid induces sodium iodide symporter expression in TPC-1 thyroid cancer cell line.
|
Nucl Med Biol
|
2012
|
0.75
|